Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938457 · ClinicalTrials.gov registry record · Phase 1
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
A Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00938457: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT00938457 is a Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00938457, a Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the side effects and best dose of stereotactic radiation therapy in treating patients with liver metastases.
Interventions
- PROCEDURE cone-beam computed tomography
- PROCEDURE implanted fiducial-based imaging
- RADIATION stereotactic radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00938457
The ClinicalTrials.gov registry entry for NCT00938457 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which cone-beam computed tomography is the first listed.
NCT00938457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00938457 about?
NCT00938457 is a clinical study titled "Stereotactic Radiation Therapy in Treating Patients With Liver Metastases". RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the side effects and best dose of stereotactic radiation therapy in treating patients with liver metastases.
What is the current status of trial NCT00938457?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2009-07.
What interventions are being tested in trial NCT00938457?
The interventions under investigation include: cone-beam computed tomography (PROCEDURE), implanted fiducial-based imaging (PROCEDURE), stereotactic radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00938457?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.